An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders… - Nature chemical …, 2006 - nature.com
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.
TR Brummelkamp, AWM Fabius… - Nature Chemical …, 2006 - search.ebscohost.com
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
[PDF][PDF] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders… - Nature - researchgate.net
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.
TR Brummelkamp, AW Fabius, J Mullenders… - Nature Chemical …, 2006 - europepmc.org
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
[引用][C] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
B TR - Nat Chem Biol, 2006 - cir.nii.ac.jp
[PDF][PDF] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders… - 2006 - academia.edu
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius… - Nature chemical …, 2006 - pubmed.ncbi.nlm.nih.gov
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
[PDF][PDF] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders… - Nature - academia.edu
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors.
TR Brummelkamp, AWM Fabius… - Nature Chemical …, 2006 - search.ebscohost.com
The identification of the cellular targets of small molecules with anticancer activity is crucial
to their further development as drug candidates. Here, we present the application of a large …
to their further development as drug candidates. Here, we present the application of a large …
[引用][C] An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp, AWM Fabius, J Mullenders… - Nature Chemical …, 2006 - cir.nii.ac.jp